VIVO Share Price

Open 18.00 Change Price %
High 18.10 1 Day 0.00 0.00
Low 17.85 1 Week 0.55 3.15
Close 18.00 1 Month 0.95 5.57
Volume 278951 1 Year -2.00 -10.00
52 Week High 21.49
52 Week Low 15.75
VIVO Important Levels
Resistance 2 18.23
Resistance 1 18.14
Pivot 17.98
Support 1 17.86
Support 2 17.77
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Meridian Bioscience Inc. (NASDAQ: VIVO)

VIVO Technical Analysis 1.5
As on 9th Dec 2016 VIVO Share Price closed @ 18.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 19.18 & Buy for SHORT-TERM with Stoploss of 17.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIVO Target for December
1st Target up-side 18.39
2nd Target up-side 19.15
3rd Target up-side 19.92
1st Target down-side 16.21
2nd Target down-side 15.45
3rd Target down-side 14.68
VIVO Other Details
Segment EQ
Market Capital 814715968.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.meridianbioscience.com
VIVO Address
VIVO
3471 River Hills Drive
Cincinnati, OH 45244
United States
Phone: 513-271-3700
Fax: 513-271-3762
Interactive Technical Analysis Chart Meridian Bioscience Inc. ( VIVO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Meridian Bioscience Inc.
VIVO Business Profile
Meridian Bioscience, Inc. (Meridian) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics and Life Science.